NYSE:SYKMedical Equipment
Are Stryker Shares Fully Priced After Strong Device Sales and Recent FDA Approvals?
If you are trying to decide what to do with Stryker stock right now, you are not alone. The company’s shares have had a busy year, climbing more than 10% over the past 12 months and sitting up over 72% year to date. That is impressive, especially considering a recent dip over the past month and an overall return of more than 100% over five years. Stryker’s ability to consistently generate revenue growth and boost its bottom line has kept investors interested, even while the broader healthcare...